EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   3.4.13.9 | -999 |
- |
- |
36091, 36099, 36107, 36115 |
| 3.4.13.9 | -999 |
- |
1412 U/l in epithelial ovarian cancer compred to 1338 U/l in controls |
708391 |
| 3.4.13.9 | -999 |
- |
45.7 U/l for control group, 53.5 U/l for patients with erectile dysfunction |
708889 |
| 3.4.13.9 | -999 |
- |
activities of strain JD6.5 enzyme in the presence or absence of various biodegradeable and water-soluble wetting agents, degreasers, or foams, overview |
707010 |
| 3.4.13.9 | -999 |
- |
assay method development and evaluation, capillary electrophoresis with Ru(bpy)3 2+ electrochemiluminescence detection, overview |
683405 |
| 3.4.13.9 | -999 |
- |
cord blood prolidase activity is 41.4 U/l in term infants and 35.2 U/l in preterm infants |
683919 |
| 3.4.13.9 | -999 |
- |
overall tissue-specific prolidase activity in brain regions with different substrates |
707929 |
| 3.4.13.9 | -999 |
- |
prolidase activity in correlation to aorta diameter, overview |
710614 |
| 3.4.13.9 | -999 |
- |
serum prolidase is 952 U/l in patients with pleural tuberculosis |
683360 |
| 3.4.13.9 | -999 |
- |
specific activities with melphalan and prodrugs in cancer cell lines, overview |
683964 |
